Influence of administration of long-chain polyunsaturated fatty acids on process of histological recovery in liver cirrhosis produced by oral intake of thioacetamide

Dig Dis Sci. 1996 Jan;41(1):197-207. doi: 10.1007/BF02208605.

Abstract

Patients with liver cirrhosis frequently show some degree of protein-energy malnutrition and obviously require nutritional support. In this study, the treatment of rats consisted of the ad libitum oral intake of a 300 mg/liter thioacetamide solution, used as drinking water for four months. Thioacetamide treatment produced a severe alteration in the plasma fatty acid profile with significant decreases of these, which mimicked changes described in human cirrhosis. This hepatotoxic agent causes nodular cirrhosis, with loss of the normal architecture of the liver and disruption of the vascular pattern. The goal of the study was to evaluate the influence of n-3 and n-6 series long-chain polyunsaturated fatty acid dietary supplementation in experimental animals and to assess the effects of those dietary components on structural recovery in the liver. Significant increases of saturated and monounsaturated fatty acids as well as n-6 polyunsaturated fatty acids were seen only in the animals given the n-6 polyunsaturated fatty acid supplemented diet. However, only rats given the standard diet exhibited some degree of histological regeneration.

MeSH terms

  • Animals
  • Dietary Fats, Unsaturated / pharmacology
  • Fatty Acids, Omega-3 / blood
  • Fatty Acids, Omega-3 / pharmacology*
  • Fatty Acids, Omega-6
  • Fatty Acids, Unsaturated / blood
  • Fatty Acids, Unsaturated / pharmacology*
  • Female
  • Lipids / blood
  • Liver / pathology
  • Liver / ultrastructure
  • Liver Cirrhosis, Experimental / blood
  • Liver Cirrhosis, Experimental / chemically induced
  • Liver Cirrhosis, Experimental / pathology*
  • Rats
  • Rats, Wistar
  • Thioacetamide

Substances

  • Dietary Fats, Unsaturated
  • Fatty Acids, Omega-3
  • Fatty Acids, Omega-6
  • Fatty Acids, Unsaturated
  • Lipids
  • Thioacetamide